- CME/CE Activities
- Interventions for Adolescents and Young Adults with Autism Spectrum Disorders
This CME/CE activity is provided by PRIME Education, Inc. (PRIME®) and is accredited for a multi-disciplinary audience of health care practitioners. This activity is supported by contract number HHSA290201000006G from the Agency for Healthcare Research and Quality. User data collected through this activity will reside on PRIME's educational portal for use by AHRQ.
Interventions for Adolescents and Young Adults with Autism Spectrum Disorders
- Program Overview
- Faculty Biographies
- Accreditation Statements
- Post-Test & Evaluation
To Receive a Certificate for This Activity:
Activity DescriptionAutism Spectrum Disorders (ASD) are among the most common neurodevelopmental disorders, with an estimated prevalence of one in 110 children in the United States having an ASD. This engaging video discussion tackles tough questions about what to do with the patient with ASD in the wake of low or insufficient evidence comparing the effectiveness of available therapies. Two experts involved in the systemic review conducted by the Agency for Healthcare Research and Quality (AHRQ) deliver thought-provoking discussions about the review findings, which center on patients aged 13-30 with ASD. Common medical and mental health issues and treatment goals in patients with ASD are discussed, including functional/adult independence, educational and occupational/vocational attainment, quality of life, and access to health and other services. The discussion also focuses on transitioning processes to increase independent functioning and the effects of interventions on family outcomes, including parent distress and satisfaction with interventions.
At the conclusion of this activity, the participant should be able to:
- Evaluate the effects of various interventions on core symptoms and common issues related to Autism Spectrum Disorder (ASD)
- Assess the value of interventions on functional behavior, family outcomes, the transitioning process, and overall social outcomes in patients with ASD
- Discuss the harms associated with various interventions used to treat adolescents and young adults with ASD
This CME activity is designed to meet the educational needs of physicians, psychologists, nurse practitioners, physician assistants, pharmacists, nurses, case managers and health educators.
Method of Participation
To receive a certificate for this activity, you should:
- Complete the learner assessment pretest
- View the entire activity online
- Complete an online evaluation & post-test
- Print your certificate online
The estimated time to complete this activity, including review of the materials, is 1.0 hour.
Term of Approval
August 31, 2012 through August 30, 2014. Original release date: August 31, 2012
Acknowledgement of Support
There is no fee for this CME/CE activity. This activity is sponsored by PRIME Education, Inc (PRIME®) and funded under contract HHSA290201000006G from the Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services (HHS).
Faculty Biographies and Disclosures
Jeremy M Veenstra-VanderWeele, MD
Assistant Professor of Psychiatry, Pediatrics, Pharmacology
Investigator, Vanderbilt Kennedy Center for Research on Human
Vanderbilt Brain Institute
Zachary E Warren, PhD
Assistant Professor of Clinical Pediatrics, Division of Developmental Medicine
Assistant Professor of Clinical Psychiatry
Director, Vanderbilt Kennedy Center Treatment and Research Institute for Autism Spectrum Disorders (TRIAD)
Director, Autism Clinical Services
Carolyn LePage, PhD, ARNP
Barry University School of Nursing
Miami Shores, FL
Heidi Wynn Maloni, PhD, ANP-BC
National Clinical Nursing Director
Department of Neurology
Multiple Sclerosis Center of Excellence, East
Veterans Affairs Medical Center
Trinity Nursing Program School of Professional Studies
Trinity Washington University
Clinical Preceptor and Instructor
Advanced Practice Programs
The Catholic University of America School of Nursing
Michele B Kaufman, PharmD, BPharm, RPh
PRN Communications, Inc
New York Downtown Hospital
New York, NY
Wanda F Carter, MPH, CHES
Adjunct Professor, Kaplan University Master of Public Health Program
Adjunct Professor, Axia College (U of Phoenix) Health Care Administration Program
Adjunct Professor, LA College International Health Care Administration Program
Adjunct Professor, Ashford University Health Care Administration Program
PHPS Alumnus, CDC Scientific Education and Professional Development Program Office
Michael N Baxley, MD, MS, MPH
Chief of Quality Medical Initiative
MCCI Medical Group
President and Founder Physician
Managed Care Consulting Service Company
Donna M Chiefari, BSc (Pharm), PharmD, RPh, FASHP
Adjunct Faculty & Preceptor
Albany College of Pharmacy
Joyce M Knestrick, PhD, CRNP, FAANP
Coordinator of Graduate Education
Frontier School of Midwifery and Family Nursing
Certified Family Nurse Practitioner
The Primary Care Center
Mt Morris, PA
Kathleen A Jarvis, MS, RN, CCM
Fort Lauderdale, FL
Physician Credit Designation Statement
PRIME Education, Inc. (PRIME®) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
PRIME® designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Physician Assistant Accreditation Statement
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME. Physician assistants may receive a maximum of 1.0 hours of Category I credit for completing this program.
Psychologist Accreditation Statement
PRIME Education, Inc. (PRIME®) is approved by the American Psychological Association to sponsor continuing education for psychologists. PRIME® maintains responsibility for this program and its content.
Nurse Practitioner Accreditation Statement
PRIME Education, Inc (PRIME®) is approved as a provider of Nurse Practitioner Continuing Education by the American Association of Nurse Practitioners. Provider number: 060815. This program is accredited for 1.0 contact hour. Program ID# CER42.
This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.
Pharmacist Accreditation Statement
This curriculum has been approved for 1.0 contact hour (0.1 CEUs) by PRIME®. PRIME® is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Activity Number for this program is 0255-0000-12-034-H01-P. This learning activity is Knowledge-Based.
Nurse Accreditation Statement
PRIME Education, Inc. (PRIME®) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
PRIME® designates this activity for 1.0 contact hour.
Case Manager Accreditation Statement
The Commission for Case Manager Certification designates this educational activity for 1.0 contact hour for certified case managers.
Certified Health Education Specialist Accreditation Statement
Sponsored by PRIME Education, Inc. (PRIME®), a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.
This program is designated for Certified Health Education Specialists (CHES) to receive up to 1.0 Category I contact hours in health education.
CHES Provider Number: MEP3774
|Faculty Name ||Advisory Board||Consultant||Grants / Research||Salary / Contractual||Supported Promotional Education||Stock / Shareholder||Other Financial Support|
|Jeremy M Veenstra-VanderWeele, MD
|Novartis, National Institute of Health||None||Novartis; Seaside Therapeutics; Roche; National Institutes of Health; Agency for Health Research of Quality; Health Resources & Services Admin; NARSAD; Vanderbilt University, Forest||None||None||None||None|
|Zachary E Warren, PhD
|None||NIMH||NIMH, NICHD, AHRQ, Autism Speaks, MCHB, Marino Autism Research Institute, Siemens Foundation||None||None||None||None|
|Carolyn LePage, PhD, ARNP
|Heidi Wynn Maloni, PhD, ANP-BC
|Michele B Kaufman, PharmD, BPharm, RPh
|Wanda F Carter, MPH, CHES
|Michael N Baxley, MD, MS, MPH
|Donna M Chiefari, BSc (Pharm), PharmD, RPh, FASHP
|Joyce M Knestrick, PhD, CRNP, FAANP
|Kathleen A Jarvis, MS, RN, CCM
|Chris R Prostko, PhD|
Scientific Program Director
|Lynn Goldenberg, RN, BSN|
Director of Accreditation & Compliance
PRIME Education Inc (PRIME®) endorses the standards of the ACCME, as well as those of the AANP, ANCC and ACPE, that require everyone in a position to control the content of a CME/CE activity to disclose all financial relationships with commercial interests that are related to the content of the CME/CE activity. CME/CE activities must be balanced, independent of commercial bias and promote improvements or quality in healthcare. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.
A conflict of interest is created when individuals in a position to control the content of CME/CE have a relevant financial relationship with a commercial interest which therefore may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.
PRIME® willidentify, review and resolve all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. Disclosure information for speakers, authors, course directors, planners, peer reviewers, and/or relevant staff are provided with this activity.
Presentations that provide information in whole or in part related to non FDA approved uses of drugs and/or devices will disclose the unlabeled indications or the investigational nature of their proposed uses to the audience. Participants should refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Participants should verify all information and data before treating patients or employing any therapies prescribed in this educational activity. The opinions expressed in the educational activity are those of the presenting faculty and do not necessarily represent the views of PRIME®, the ACCME, AANP, ACPE, ANCC and other relevant accreditation bodies.
Content validation methods are consistently utilized by PRIME® to ensure that all program content is evidence-based, fair-balanced, and developed with scientific rigor and integrity. All clinical recommendations are based on evidence accepted within the medical profession. All scientific research referred to, reported or used to support a clinical recommendation conforms to accepted standards of experimental design, data collection and analysis. In addition to review of content by course directors and expert faculty, content is also validated through independent peer reviewers selected for their expertise in the content area, as well as their experience in the intended audience. All peer reviewers, planners, course directors, faculty and relevant staff utilized by PRIME® complete disclosures which are related to their role in the educational activity.
PRIME®is committed to providing access to our CME programs for individuals with disabilities as identified in Section 508 of the Rehabilitation Act for all web-based programs. This website is 508 compliant.